SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $132,000 | -93.4% | 317,962 | -68.2% | 0.02% | -94.6% |
Q3 2018 | $2,000,000 | -29.3% | 1,000,000 | -31.4% | 0.31% | -43.3% |
Q3 2017 | $2,828,000 | -26.8% | 1,457,712 | +1.9% | 0.55% | -20.5% |
Q2 2017 | $3,864,000 | -38.7% | 1,431,149 | -6.9% | 0.69% | -44.7% |
Q1 2017 | $6,305,000 | +13.3% | 1,537,873 | 0.0% | 1.25% | +9.4% |
Q4 2016 | $5,567,000 | +19.8% | 1,537,873 | +44.6% | 1.14% | -3.5% |
Q3 2016 | $4,648,000 | – | 1,063,573 | – | 1.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,125,000 | $4,505,000 | 0.51% |
DAFNA Capital Management LLC | 373,702 | $792,000 | 0.37% |
BVF INC/IL | 1,684,636 | $3,571,000 | 0.35% |
OIKOS HOLDINGS LLC | 182,395 | $387,000 | 0.24% |
Eventide Asset Management | 2,265,455 | $4,803,000 | 0.20% |
SABBY MANAGEMENT, LLC | 512,036 | $1,086,000 | 0.17% |
NEA Management Company, LLC | 1,298,274 | $2,752,000 | 0.13% |
Palo Alto Investors LP | 1,162,473 | $2,464,000 | 0.10% |
Rhenman & Partners Asset Management AB | 427,642 | $907,000 | 0.09% |
Telemetry Investments, L.L.C. | 90,781 | $192,000 | 0.07% |